Health
South African variant can ‘break through’ Pfizer vaccine, Israeli study says – Reuters
The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found,…
By Maayan Lubell
JERUSALEM (Reuters) – The coronavirus variant discovered in South Africa can break through Pfizer/BioNTechs COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients…
-
Business16 hours agoThink Nvidia stock is expensive? This chart might change your mind.
-
General23 hours agoFormer Ukrainian parliament speaker Andriy Parubiy murdered in Lviv
-
Noosa News16 hours agoYoung rockers prepare to hit the stage in Eumundi
-
General22 hours agoThree dead after angry mob sets fire to parliament building in Indonesia